Epigenetic De-Repression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression

Scientists functionally characterized the role of prospero-homeobox 1 (PROX1) in neuroendocrine prostate cancer (NEPC). An unbiased CRISPR screen in two NEPC patient-derived organoid models demonstrated high cellular dependency for PROX1.